--- 
layout: page 
image:
  feature: DaubEnginePatent.jpg
--- 
   <head>
      <title>2113-</title>
      <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
</head>
      <li><a href="index.html">Manual of Patent Examining Procedure</a></li>
      <li><a href="mpep-2100.html"><span>Chapter 2100</span></a></li>
      <li><span>Section 2113</span></li>  </ul>  </div>
      <div id="yui-main">
         <div class="yui-b">
            <div class="yui-g">  <div xmlns:bf="http://www.uspto.gov/bf" id="article">
               <div>
                  <div xmlns="" class="Section" id="d0e201450">
                     <h1 class="page-title">2113
                        &nbsp;&nbsp;
                        Product-by-Process Claims [R-08.2012]
                     </h1>
                     <div class="Section">
                        <h2 class="section1" id="d0e201454">
                           &nbsp;&nbsp;PRODUCT-BY-PROCESS CLAIMS ARE NOT LIMITED TO THE MANIPULATIONS
                           OF THE RECITED STEPS, ONLY THE STRUCTURE IMPLIED BY THE STEPS
                        </h2>
                        <p id="d0e201458">“[E]ven though product-by-process claims are limited by and
                           defined by the process, determination of patentability is based on the product itself.
                           The patentability of a product does not depend on its method of production. If the
                           product in the product-by-process claim is the same as or obvious from a product of the
                           prior art, the claim is unpatentable even though the prior product was made by a
                           different process.” <i> In re Thorpe,</i> 777 F.2d 695,
                           698, 227 USPQ 964, 966 (Fed. Cir. 1985) (citations omitted) (Claim was directed to a
                           novolac color developer. The process of making the developer was allowed. The difference
                           between the inventive process and the prior art was the addition of metal oxide and
                           carboxylic acid as separate ingredients instead of adding the more expensive pre-reacted
                           metal carboxylate. The product-by-process claim was rejected because the end product, in
                           both the prior art and the allowed process, ends up containing metal carboxylate. The
                           fact that the metal carboxylate is not directly added, but is instead produced in-situ
                           does not change the end product.). Furthermore, 
                           "[b]ecause validity
                           is determined based on the requirements of patentability, a patent is invalid if a
                           product made by the process recited in a product-by-process claim is anticipated by
                           or obvious from prior art products, even if those prior art products are made by
                           different processes."
                           
                           
                           <i>Amgen Inc. v. F. Hoffman-La Roche Ltd.,</i> 580 F.3d 1340, 1370 n 14, 92
                           USPQ2d 1289, 1312, n 14 (Fed. Cir. 2009). However, in the context of an infringement
                           analysis, a product-by-process claim is only infringed by a product made by the process
                           recited in the claim. <i>Id.</i> at 1370 (
                           "a product in
                           the prior art made by a different process can anticipate a product-by-process claim,
                           but an accused product made by a different process cannot infringe a
                           product-by-process claim."
                           
                           
                           ). 
                        </p>
                        <p id="d0e201464"> The structure implied by the process steps should be
                           considered when assessing the patentability of product-by-process claims over the prior
                           art, especially where the product can only be defined by the process steps by which the
                           product is made, or where the manufacturing process steps would be expected to impart
                           distinctive structural characteristics to the final product. See, e.g., <i>In re Garnero,</i> 412 F.2d 276, 279, 162 USPQ 221, 223 (CCPA
                           1979) (holding “interbonded by interfusion” to limit structure of the claimed composite
                           and noting that terms such as “welded,” “intermixed,” “ground in place,” “press fitted,”
                           and “etched” are capable of construction as structural limitations.)
                        </p>
                     </div>
                     <div class="Section">
                        <h2 class="section1" id="d0e201471">
                           &nbsp;&nbsp;ONCE A PRODUCT APPEARING TO BE SUBSTANTIALLY IDENTICAL IS FOUND
                           AND A 35 U.S.C. 102/103 REJECTION MADE, THE BURDEN SHIFTS TO THE APPLICANT TO SHOW AN
                           UNOBVIOUS DIFFERENCE
                        </h2>
                        <p id="d0e201481">“The Patent Office bears a lesser burden of proof in making
                           out a case of <i>prima facie</i> obviousness for
                           product-by-process claims because of their peculiar nature” than when a product is
                           claimed in the conventional fashion. <i>In re Fessmann,</i>
                           489 F.2d 742, 744, 180 USPQ 324, 326 (CCPA 1974). Once the examiner provides a rationale
                           tending to show that the claimed product appears to be the same or similar to that of
                           the prior art, although produced by a different process, the burden shifts to applicant
                           to come forward with evidence establishing an unobvious difference between the claimed
                           product and the prior art product. <i>In re Marosi,</i> 710
                           F.2d 798, 802, 218 USPQ 289, 292 (Fed. Cir. 1983) (The claims were directed to a zeolite
                           manufactured by mixing together various inorganic materials in solution and heating the
                           resultant gel to form a crystalline metal silicate essentially free of alkali metal. The
                           prior art described a process of making a zeolite which, after ion exchange to remove
                           alkali metal, appeared to be “essentially free of alkali metal.” The court upheld the
                           rejection because the applicant had not come forward with any evidence that the prior
                           art was not “essentially free of alkali metal” and therefore a different and unobvious
                           product.). 
                        </p>
                        <p id="d0e201493"><i>Ex parte Gray,</i> 10 USPQ2d 1922 (Bd. Pat. App. &amp;
                           Inter. 1989) (The prior art disclosed human nerve growth factor (b-NGF) isolated from
                           human placental tissue. The claim was directed to b-NGF produced through genetic
                           engineering techniques. The factor produced seemed to be substantially the same whether
                           isolated from tissue or produced through genetic engineering. While the applicant
                           questioned the purity of the prior art factor, no concrete evidence of an unobvious
                           difference was presented. The Board stated that the dispositive issue is whether the
                           claimed factor exhibits any unexpected properties compared with the factor disclosed by
                           the prior art. The Board further stated that the applicant should have made some
                           comparison between the two factors to establish unexpected properties since the
                           materials appeared to be identical or only slightly different.).
                        </p>
                     </div>
                     <div class="Section">
                        <h2 class="section1" id="d0e201498">
                           &nbsp;&nbsp;THE USE OF 35 U.S.C. 102/103 REJECTIONS FOR PRODUCT-BY-PROCESS
                           CLAIMS HAS BEEN APPROVED BY THE COURTS
                        </h2>
                        <p id="d0e201508">“[T]he lack of physical description in a product-by-process
                           claim makes determination of the patentability of the claim more difficult, since in
                           spite of the fact that the claim may recite only process limitations, it is the
                           patentability of the product claimed and not of the recited process steps which must be
                           established. We are therefore of the opinion that when the prior art discloses a product
                           which reasonably appears to be either identical with or only slightly different than a
                           product claimed in a product-by-process claim, a rejection based alternatively on either
                           <b><a href="mpep-9015-appx-l.html#d0e302383">section 102</a></b> or <b><a href="mpep-9015-appx-l.html#d0e302450">section 103</a></b> of the
                           statute is eminently fair and acceptable. As a practical matter, the Patent Office is
                           not equipped to manufacture products by the myriad of processes put before it and then
                           obtain prior art products and make physical comparisons therewith.” <i>In re Brown,</i> 459&nbsp;F.2d 531, 535, 173 USPQ 685, 688 (CCPA
                           1972). Office personnel should note that reliance on the alternative grounds of
                           <b><a href="mpep-9015-appx-l.html#al_d1fbe1_234ed_52">35 U.S.C.
                                 102</a></b> or <b><a href="mpep-9015-appx-l.html#al_d1fbe1_19797_b0">35 U.S.C. 103</a></b> does not eliminate the
                           need to explain both the anticipation and obviousness aspects of the
                           rejections.
                        </p>
                     </div>
                     <p align="right"><a href="#top">[top]</a></p>
                  </div>
               </div>
               <div>
                  <h1 class="page-title">&nbsp;</h1>
               </div>  </div>
            </div>
         </div>
      </div>
      <div class="yui-b">
         <div id="aside">  <div id="rdms-sub-nav-container" xmlns:bf="http://www.uspto.gov/bf">
            <ul id="sub-nav">
               <li xmlns=""><a href="s2101-2102.html">2101-2102-[Reserved]</a></li>
               <li xmlns=""><a href="s2103.html">2103-Patent Examination Process</a></li>
               <li xmlns=""><a href="s2104.html">2104-Patentable Subject Matter</a></li>
               <li xmlns=""><a href="s2105.html">2105-Patentable Subject Matter — Living Subject Matter</a></li>
               <li xmlns=""><a href="s2106.html">2106-Patent Subject Matter Eligibility</a><ul>
                     <li><a href="s2106.html#d0e198001">2106.01-Subject Matter Eligibility Analysis of Process Claims Involving Laws of Nature</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2107.html">2107-Guidelines for Examination of Applications for Compliance with the Utility Requirement</a><ul>
                     <li><a href="s2107.html#d0e198682">2107.01-General Principles Governing Utility Rejections</a></li>
                     <li><a href="s2107.html#d0e199419">2107.02-Procedural Considerations Related to Rejections for Lack of Utility</a></li>
                     <li><a href="s2107.html#d0e200058">2107.03-Special Considerations for Asserted Therapeutic or Pharmacological Utilities</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2108-2110.html">2108-2110-[Reserved]</a></li>
               <li xmlns=""><a href="s2111.html">2111-Claim Interpretation; Broadest Reasonable Interpretation</a><ul>
                     <li><a href="s2111.html#d0e200409">2111.01-Plain Meaning</a></li>
                     <li><a href="s2111.html#d0e200689">2111.02-Effect of Preamble</a></li>
                     <li><a href="s2111.html#d0e200824">2111.03-Transitional Phrases</a></li>
                     <li><a href="s2111.html#d0e201000">2111.04-“Adapted to,” “Adapted for,” “Wherein,” and “Whereby” Clauses</a></li>
                     <li><a href="s2111.html#ch2100_d1b148_1ea0c_2c0">2111.05-Functional and Nonfunctional Descriptive Material</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2112.html">2112-Requirements of Rejection Based on Inherency; Burden of Proof</a><ul>
                     <li><a href="s2112.html#d0e201273">2112.01-Composition, Product, and&nbsp; Apparatus Claims</a></li>
                     <li><a href="s2112.html#d0e201360">2112.02-Process Claims</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2113.html">2113-Product-by-Process Claims</a></li>
               <li xmlns=""><a href="s2114.html">2114-Apparatus and Article Claims — Functional Language</a></li>
               <li xmlns=""><a href="s2115.html">2115-Material or Article Worked Upon by Apparatus</a></li>
               <li xmlns=""><a href="s2116.html">2116-Material Manipulated in Process</a><ul>
                     <li><a href="s2116.html#d0e201660">2116.01-Novel, Unobvious Starting Material or End Product</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2117-2120.html">2117-2120-[Reserved]</a></li>
               <li xmlns=""><a href="s2121.html">2121-Prior Art; General Level of Operability Required to Make a Prima Facie Case</a><ul>
                     <li><a href="s2121.html#d0e201800">2121.01-Use of Prior Art in Rejections Where Operability is in Question</a></li>
                     <li><a href="s2121.html#d0e201868">2121.02-Compounds and Compositions — What Constitutes Enabling Prior Art</a></li>
                     <li><a href="s2121.html#d0e201937">2121.03-Plant Genetics — What Constitutes Enabling Prior Art</a></li>
                     <li><a href="s2121.html#d0e201980">2121.04-Apparatus and Articles — What Constitutes Enabling Prior Art</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2122.html">2122-Discussion of Utility in the Prior Art</a></li>
               <li xmlns=""><a href="s2123.html">2123-Rejection Over Prior Art’s Broad Disclosure Instead of Preferred Embodiments</a></li>
               <li xmlns=""><a href="s2124.html">2124-Exception to the Rule That the Critical Reference Date Must Precede the Filing Date</a><ul>
                     <li><a href="s2124.html#ch2100_d1b13f_20224_b9">2124.01-Tax Strategies Deemed Within the Prior Art</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2125.html">2125-Drawings as Prior Art</a></li>
               <li xmlns=""><a href="s2126.html">2126-Availability of a Document as a “Patent” for Purposes of Rejection Under 35 U.S.C. 102(a) or Pre-AIA 35 U.S.C. 102(a), (b),
                     and (d)</a><ul>
                     <li><a href="s2126.html#d0e202293">2126.01-Date of Availability of a Patent as a Reference</a></li>
                     <li><a href="s2126.html#d0e202334">2126.02-Scope of Reference’s Disclosure Which Can Be Used to Reject Claims When the Reference Is a “Patent” but Not a “Publication”</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2127.html">2127-Domestic and Foreign Patent Applications as Prior Art</a></li>
               <li xmlns=""><a href="s2128.html">2128-“Printed Publications” as Prior Art</a><ul>
                     <li><a href="s2128.html#d0e202706">2128.01-Level of Public Accessibility Required</a></li>
                     <li><a href="s2128.html#d0e202804">2128.02-Date Publication Is Available as a Reference</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2129.html">2129-Admissions as Prior Art</a></li>
               <li xmlns=""><a href="s2130.html">2130-[Reserved]</a></li>
               <li xmlns=""><a href="s2131.html">2131-Anticipation — Application of 35&nbsp;U.S.C. 102</a><ul>
                     <li><a href="s2131.html#d0e203057">2131.01-Multiple Reference 35 U.S.C. 102 Rejections</a></li>
                     <li><a href="s2131.html#d0e203166">2131.02-Genus-Species Situations</a></li>
                     <li><a href="s2131.html#d0e203269">2131.03-Anticipation of Ranges</a></li>
                     <li><a href="s2131.html#d0e203338">2131.04-Secondary Considerations</a></li>
                     <li><a href="s2131.html#d0e203351">2131.05-Nonanalogous or Disparaging Prior Art</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2132.html">2132-Pre-AIA 35 U.S.C. 102(a)</a><ul>
                     <li><a href="s2132.html#d0e203530">2132.01-Publications as Pre-AIA 35 U.S.C. 102(a) Prior Art</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2133.html">2133-Pre-AIA 35 U.S.C. 102(b)</a><ul>
                     <li><a href="s2133.html#d0e203726">2133.01-Rejections of Continuation-In-Part (CIP) Applications</a></li>
                     <li><a href="s2133.html#d0e203739">2133.02-Rejections Based on Publications and Patents</a></li>
                     <li><a href="s2133.html#d0e203781">2133.03-Rejections Based on “Public Use” or “On Sale”</a><ul style="list-style-type: none">
                           <li><a href="s2133.html#d0e203899">2133.03(a)-“Public Use”</a></li>
                           <li><a href="s2133.html#d0e204201">2133.03(b)-“On Sale”</a></li>
                           <li><a href="s2133.html#d0e204494">2133.03(c)-The “Invention”</a></li>
                           <li><a href="s2133.html#d0e204651">2133.03(d)-“In This Country”</a></li>
                           <li><a href="s2133.html#d0e204670">2133.03(e)-Permitted Activity; Experimental Use</a><ul>
                                 <li><a href="s2133.html#d0e204712">2133.03(e)(1)-Commercial Exploitation</a></li>
                                 <li><a href="s2133.html#d0e204884">2133.03(e)(2)-Intent</a></li>
                                 <li><a href="s2133.html#d0e204900">2133.03(e)(3)-“Completeness” of the Invention</a></li>
                                 <li><a href="s2133.html#d0e204981">2133.03(e)(4)-Factors Indicative of an Experimental Purpose</a></li>
                                 <li><a href="s2133.html#d0e205019">2133.03(e)(5)-Experimentation and Degree of Supervision and Control</a></li>
                                 <li><a href="s2133.html#d0e205061">2133.03(e)(6)-Permitted Experimental Activity and Testing</a></li>
                                 <li><a href="s2133.html#d0e205133">2133.03(e)(7)-Activity of an Independent Third Party Inventor</a></li>
                              </ul>
                           </li>
                        </ul>
                     </li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2134.html">2134-Pre-AIA 35 U.S.C. 102(c)</a></li>
               <li xmlns=""><a href="s2135.html">2135-Pre-AIA 35 U.S.C. 102(d)</a><ul>
                     <li><a href="s2135.html#d0e205339">2135.01-The Four Requirements of Pre-AIA 35 U.S.C. 102(d)</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2136.html">2136-Pre-AIA 35 U.S.C. 102(e)</a><ul>
                     <li><a href="s2136.html#d0e205680">2136.01-Status of U.S. Application as a Reference</a></li>
                     <li><a href="s2136.html#d0e205829">2136.02-Content of the Prior Art Available Against the Claims</a></li>
                     <li><a href="s2136.html#d0e205924">2136.03-Critical Reference Date</a></li>
                     <li><a href="s2136.html#d0e206254">2136.04-Different Inventive Entity; Meaning of “By Another”</a></li>
                     <li><a href="s2136.html#d0e206333">2136.05-Overcoming a Rejection Under Pre-AIA 35&nbsp;U.S.C. 102(e)</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2137.html">2137-Pre-AIA 35 U.S.C. 102(f)</a><ul>
                     <li><a href="s2137.html#d0e206713">2137.01-Inventorship</a></li>
                     <li><a href="s2137.html#d0e206972">2137.02-Applicability of Pre-AIA 35 U.S.C. 103(c)</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2138.html">2138-Pre-AIA 35 U.S.C. 102(g)</a><ul>
                     <li><a href="s2138.html#d0e207148">2138.01-Interference Practice</a></li>
                     <li><a href="s2138.html#d0e207398">2138.02-“The Invention Was Made in This Country”</a></li>
                     <li><a href="s2138.html#d0e207478">2138.03-“By Another Who Has Not Abandoned, Suppressed, or Concealed It”</a></li>
                     <li><a href="s2138.html#d0e207607">2138.04-“Conception”</a></li>
                     <li><a href="s2138.html#d0e207753">2138.05-“Reduction to Practice”</a></li>
                     <li><a href="s2138.html#d0e207967">2138.06-“Reasonable Diligence”</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2139-2140.html">2139-2140-[Reserved]</a></li>
               <li xmlns=""><a href="s2141.html">2141-Examination Guidelines for Determining Obviousness Under 35 U.S.C. 103</a><ul>
                     <li><a href="s2141.html#d0e208803">2141.01-Scope and Content of the Prior Art</a><ul style="list-style-type: none">
                           <li><a href="s2141.html#d0e208985">2141.01(a)-Analogous and Nonanalogous Art</a></li>
                        </ul>
                     </li>
                     <li><a href="s2141.html#d0e209106">2141.02-Differences Between Prior Art and Claimed Invention</a></li>
                     <li><a href="s2141.html#d0e209300">2141.03-Level of Ordinary Skill in the Art</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2142.html">2142-Legal Concept of Prima Facie Obviousness</a></li>
               <li xmlns=""><a href="s2143.html">2143-Examples of Basic Requirements of a Prima Facie Case of Obviousness</a><ul>
                     <li><a href="s2143.html#d0e210245">2143.01-Suggestion or Motivation To Modify the References</a></li>
                     <li><a href="s2143.html#d0e210414">2143.02-Reasonable Expectation of Success Is Required</a></li>
                     <li><a href="s2143.html#d0e210501">2143.03-All Claim Limitations Must Be Considered</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2144.html">2144-Supporting a Rejection Under 35 U.S.C. 103</a><ul>
                     <li><a href="s2144.html#d0e210719">2144.01-Implicit Disclosure</a></li>
                     <li><a href="s2144.html#d0e210732">2144.02-Reliance on Scientific Theory</a></li>
                     <li><a href="s2144.html#d0e210752">2144.03-Reliance on Common Knowledge in the Art or “Well Known” Prior Art</a></li>
                     <li><a href="s2144.html#d0e210929">2144.04-Legal Precedent as Source of Supporting Rationale</a></li>
                     <li><a href="s2144.html#d0e211255">2144.05-Obviousness of Ranges</a></li>
                     <li><a href="s2144.html#d0e211480">2144.06-Art Recognized Equivalence for the Same Purpose</a></li>
                     <li><a href="s2144.html#d0e211558">2144.07-Art Recognized Suitability for an Intended Purpose</a></li>
                     <li><a href="s2144.html#d0e211596">2144.08-Obviousness of Species When Prior Art Teaches Genus</a></li>
                     <li><a href="s2144.html#d0e212153">2144.09-Close Structural Similarity Between Chemical Compounds (Homologs, Analogues, Isomers)</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2145.html">2145-Consideration of Applicant’s Rebuttal Arguments</a></li>
               <li xmlns=""><a href="s2146.html">2146-Pre-AIA 35 U.S.C. 103(c)</a></li>
               <li xmlns=""><a href="s2147-2149.html">2147-2149-[Reserved]</a></li>
               <li xmlns=""><a href="s2150.html">2150-Examination Guidelines for 35 U.S.C. 102 and 103 as Amended by the First Inventor To File Provisions of the Leahy-Smith America
                     Invents Act</a></li>
               <li xmlns=""><a href="s2151.html">2151-Overview of the Changes to 35 U.S.C. 102 and 103 in the AIA</a></li>
               <li xmlns=""><a href="s2152.html">2152-Detailed Discussion of AIA 35 U.S.C. 102(a) and (b)</a><ul>
                     <li><a href="s2152.html#ch2100_d20033_1afb3_e6">2152.01-Effective Filing Date of the Claimed Invention</a></li>
                     <li><a href="s2152.html#ch2100_d20033_1d66c_1e5">2152.02-Prior Art Under AIA 35 U.S.C. 102(a)(1) (Patented, Described in a Printed Publication, or in Public Use, on Sale, or Otherwise
                           Available to the Public)</a><ul style="list-style-type: none">
                           <li><a href="s2152.html#ch2100_d20033_1d6c2_3b7">2152.02(a)-Patented</a></li>
                           <li><a href="s2152.html#ch2100_d20033_1da60_2e9">2152.02(b)-Described in a Printed Publication</a></li>
                           <li><a href="s2152.html#ch2100_d20033_1e416_252">2152.02(c)-In Public Use</a></li>
                           <li><a href="s2152.html#ch2100_d20033_2254b_3e0">2152.02(d)-On Sale</a></li>
                           <li><a href="s2152.html#ch2100_d20033_228c0_21c">2152.02(e)-Otherwise Available to the Public</a></li>
                           <li><a href="s2152.html#ch2100_d20033_232ba_27c">2152.02(f)-No Requirement of "By Others"</a></li>
                        </ul>
                     </li>
                     <li><a href="s2152.html#ch2100_d20033_23444_146">2152.03-Admissions</a></li>
                     <li><a href="s2152.html#ch2100_d20033_236db_f9">2152.04-The Meaning of "Disclosure"</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2153.html">2153-Prior Art Exceptions Under 35 U.S.C. 102(b)(1) to AIA 35 U.S.C. 102(a)(1)</a><ul>
                     <li><a href="s2153.html#ch2100_d20033_24caf_cd">2153.01-Prior Art Exception Under AIA 35 U.S.C. 102(b)(1)(A) To AIA 35 U.S.C. 102(a)(1) (Grace Period Inventor Or Inventor-Originated
                           Disclosure Exception)</a><ul style="list-style-type: none">
                           <li><a href="s2153.html#ch2100_d20033_24e66_2ac">2153.01(a)-Grace Period Inventor Disclosure Exception</a></li>
                           <li><a href="s2153.html#ch2100_d20033_256f4_147">2153.01(b)-Grace Period Inventor-Originated Disclosure Exception</a></li>
                        </ul>
                     </li>
                     <li><a href="s2153.html#ch2100_d20033_25935_125">2153.02-Prior Art Exception Under AIA 35 U.S.C. 102(b)(1)(B) to AIA 35 U.S.C. 102(a)(1) (Inventor Or Inventor-Originated Prior Public
                           Disclosure Exception)</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2154.html">2154-Provisions Pertaining to Subject Matter in a U.S. Patent or Application Effectively Filed Before the Effective Filing Date
                     of the Claimed Invention</a><ul>
                     <li><a href="s2154.html#ch2100_d20033_27642_39b">2154.01-Prior Art Under AIA 35 U.S.C. 102(a)(2) “U.S. Patent Documents”</a><ul style="list-style-type: none">
                           <li><a href="s2154.html#ch2100_d20034_11f3b_a0">2154.01(a)-WIPO Published Applications</a></li>
                           <li><a href="s2154.html#ch2100_d20034_12188_300">2154.01(b)-Determining When Subject Matter Was Effectively Filed Under AIA 35 U.S.C. 102(d)</a></li>
                           <li><a href="s2154.html#ch2100_d20034_13884_7c">2154.01(c)-Requirement Of “Names Another Inventor”</a></li>
                        </ul>
                     </li>
                     <li><a href="s2154.html#ch2100_d20034_139ac_31b">2154.02-Prior Art Exceptions Under 35 U.S.C. 102(b)(2) to AIA 35 U.S.C. 102(a)(2)</a><ul style="list-style-type: none">
                           <li><a href="s2154.html#ch2100_d20034_13f89_241">2154.02(a)-Prior Art Exception Under AIA 35 U.S.C. 102(b)(2)(A) to AIA 35 U.S.C. 102(a)(2) (Inventor-Originated Disclosure Exception)</a></li>
                           <li><a href="s2154.html#ch2100_d20034_140df_1a6">2154.02(b)-Prior Art Exception Under AIA 35 U.S.C. 102(b)(2)(B) to AIA 35 U.S.C. 102(a)(2) (Inventor or Inventor-Originated Prior Public
                                 Disclosure Exception)</a></li>
                           <li><a href="s2154.html#ch2100_d20034_145f0_210">2154.02(c)-Prior Art Exception Under AIA 35 U.S.C. 102(b)(2)(C) to AIA 35 U.S.C. 102(a)(2) (Common Ownership or Obligation of Assignment)</a></li>
                        </ul>
                     </li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2155.html">2155-Use of Affidavits or Declarations Under 37 CFR 1.130 To Overcome Prior Art Rejections</a><ul>
                     <li><a href="s2155.html#ch2100_d20034_17271_83">2155.01-Showing That the Disclosure Was Made by the Inventor or a Joint Inventor</a></li>
                     <li><a href="s2155.html#ch2100_d20034_173e3_369">2155.02-Showing That the Subject Matter Disclosed Had Been Previously Publicly Disclosed by the Inventor or a Joint Inventor</a></li>
                     <li><a href="s2155.html#ch2100_d20034_1891a_11">2155.03-Showing That the Disclosure was Made, or That Subject Matter had Been Previously Publicly Disclosed, by Another Who Obtained
                           the Subject Matter Disclosed Directly or Indirectly From the Inventor or a Joint Inventor</a></li>
                     <li><a href="s2155.html#ch2100_d20034_19332_1dd">2155.04-Enablement</a></li>
                     <li><a href="s2155.html#ch2100_d20034_1b102_307">2155.05-Who May File an Affidavit or Declaration Under 37 CFR 1.130</a></li>
                     <li><a href="s2155.html#ch2100_d20034_1b27e_391">2155.06-Situations in Which an Affidavit or Declaration Is Not Available</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2156.html">2156-Joint Research Agreements</a></li>
               <li xmlns=""><a href="s2157.html">2157-Improper Naming of Inventors</a></li>
               <li xmlns=""><a href="s2158.html">2158-AIA 35 U.S.C. 103</a></li>
               <li xmlns=""><a href="s2159.html">2159-Applicability Date Provisions and Determining Whether an Application Is Subject to the First Inventor To File Provisions of
                     the AIA</a><ul>
                     <li><a href="s2159.html#ch2100_d20034_1dc9d_3c4">2159.01-Applications Filed Before March 16, 2013</a></li>
                     <li><a href="s2159.html#ch2100_d20034_1dfd4_279">2159.02-Applications Filed on or After March 16, 2013</a></li>
                     <li><a href="s2159.html#ch2100_d222e3_13adb_2f9">2159.03-Applications Subject to the AIA but Also Containing a Claimed Invention Having an Effective Filing Date Before March 16, 2013</a></li>
                     <li><a href="s2159.html#ch2100_d222e3_140d7_1bb">2159.04-Applicant Statement in Transition Applications Containing a Claimed Invention Having an Effective Filing Date on or After
                           March 16, 2013</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2160.html">2160-[Reserved]</a></li>
               <li xmlns=""><a href="s2161.html">2161-Three Separate Requirements for Specification Under 35 U.S.C. 112(a) or Pre-AIA 35 U.S.C. 112, First Paragraph</a><ul>
                     <li><a href="s2161.html#d0e213447">2161.01-Computer Programming and 35 U.S.C. 112(a) or Pre-AIA 35&nbsp;U.S.C. 112, First Paragraph</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2162.html">2162-Policy Underlying 35 U.S.C. 112(a) or Pre-AIA 35 U.S.C. 112, First Paragraph</a></li>
               <li xmlns=""><a href="s2163.html">2163-Guidelines for the Examination of Patent Applications Under the 35 U.S.C. 112(a) or Pre-AIA 35&nbsp;U.S.C. 112, para. 1, “Written
                     Description” Requirement</a><ul>
                     <li><a href="s2163.html#d0e214533">2163.01-Support for the Claimed Subject Matter in Disclosure</a></li>
                     <li><a href="s2163.html#d0e214553">2163.02-Standard for Determining Compliance With the Written Description Requirement</a></li>
                     <li><a href="s2163.html#d0e214623">2163.03-Typical Circumstances Where Adequate Written Description Issue Arises</a></li>
                     <li><a href="s2163.html#d0e214731">2163.04-Burden on the Examiner with Regard to the Written Description Requirement</a></li>
                     <li><a href="s2163.html#d0e214820">2163.05-Changes to the Scope of Claims</a></li>
                     <li><a href="s2163.html#d0e215023">2163.06-Relationship of Written Description Requirement to New Matter</a></li>
                     <li><a href="s2163.html#d0e215099">2163.07-Amendments to Application Which Are Supported in the Original Description</a><ul style="list-style-type: none">
                           <li><a href="s2163.html#d0e215172">2163.07(a)-Inherent Function, Theory, or Advantage</a></li>
                           <li><a href="s2163.html#d0e215198">2163.07(b)-Incorporation by Reference</a></li>
                        </ul>
                     </li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2164.html">2164-The Enablement Requirement</a><ul>
                     <li><a href="s2164.html#d0e215268">2164.01-Test of Enablement</a><ul style="list-style-type: none">
                           <li><a href="s2164.html#d0e215360">2164.01(a)-Undue Experimentation Factors</a></li>
                           <li><a href="s2164.html#d0e215447">2164.01(b)-How to Make the Claimed Invention</a></li>
                           <li><a href="s2164.html#d0e215491">2164.01(c)-How to Use the Claimed Invention</a></li>
                        </ul>
                     </li>
                     <li><a href="s2164.html#d0e215531">2164.02-Working Example</a></li>
                     <li><a href="s2164.html#d0e215634">2164.03-Relationship of Predictability of the Art and the Enablement Requirement</a></li>
                     <li><a href="s2164.html#d0e215702">2164.04-Burden on the Examiner Under the Enablement Requirement</a></li>
                     <li><a href="s2164.html#d0e215797">2164.05-Determination of Enablement Based on Evidence as a Whole</a><ul style="list-style-type: none">
                           <li><a href="s2164.html#d0e215860">2164.05(a)-Specification Must Be Enabling as of the Filing Date</a></li>
                           <li><a href="s2164.html#d0e215949">2164.05(b)-Specification Must Be Enabling to Persons Skilled in the Art</a></li>
                        </ul>
                     </li>
                     <li><a href="s2164.html#d0e215984">2164.06-Quantity of Experimentation</a><ul style="list-style-type: none">
                           <li><a href="s2164.html#d0e216038">2164.06(a)-Examples of Enablement Issues-Missing Information</a></li>
                           <li><a href="s2164.html#d0e216163">2164.06(b)-Examples of Enablement Issues — Chemical Cases</a></li>
                           <li><a href="s2164.html#d0e216273">2164.06(c)-Examples of Enablement Issues – Computer Programming Cases</a></li>
                        </ul>
                     </li>
                     <li><a href="s2164.html#d0e216498">2164.07-Relationship of Enablement Requirement to Utility Requirement of 35 U.S.C. 101</a></li>
                     <li><a href="s2164.html#d0e216700">2164.08-Enablement Commensurate in Scope With the Claims</a><ul style="list-style-type: none">
                           <li><a href="s2164.html#d0e216855">2164.08(a)-Single Means Claim</a></li>
                           <li><a href="s2164.html#d0e216871">2164.08(b)-Inoperative Subject Matter</a></li>
                           <li><a href="s2164.html#d0e216899">2164.08(c)-Critical Feature Not Claimed</a></li>
                        </ul>
                     </li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2165.html">2165-The Best Mode Requirement</a><ul>
                     <li><a href="s2165.html#d0e216999">2165.01-Considerations Relevant to Best Mode</a></li>
                     <li><a href="s2165.html#d0e217148">2165.02-Best Mode Requirement Compared to Enablement Requirement</a></li>
                     <li><a href="s2165.html#d0e217195">2165.03-Requirements for Rejection for Lack of Best Mode</a></li>
                     <li><a href="s2165.html#d0e217264">2165.04-Examples of Evidence of Concealment</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2166-2170.html">2166-2170-[Reserved]</a></li>
               <li xmlns=""><a href="s2171.html">2171-Two Separate Requirements for Claims Under 35 U.S.C. 112 (b) or Pre-AIA 35 U.S.C. 112, Second Paragraph</a></li>
               <li xmlns=""><a href="s2172.html">2172-Subject Matter Which the Inventor or a Joint Inventor Regards as The Invention</a><ul>
                     <li><a href="s2172.html#d0e217526">2172.01-Unclaimed Essential Matter</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2173.html">2173-Claims Must Particularly Point Out and Distinctly Claim the Invention</a><ul>
                     <li><a href="s2173.html#d0e217578">2173.01-Interpreting the Claims</a></li>
                     <li><a href="s2173.html#d0e217598">2173.02-Determining Whether Claim Language is Definite</a></li>
                     <li><a href="s2173.html#d0e217747">2173.03-Correspondence Between Specification and Claims</a></li>
                     <li><a href="s2173.html#d0e217778">2173.04-Breadth Is Not Indefiniteness</a></li>
                     <li><a href="s2173.html#d0e217809">2173.05-Specific Topics Related to Issues Under 35 U.S.C. 112(b) or Pre-AIA 35 U.S.C. 112, Second Paragraph</a><ul style="list-style-type: none">
                           <li><a href="s2173.html#d0e217839">2173.05(a)-New Terminology</a></li>
                           <li><a href="s2173.html#d0e217939">2173.05(b)-Relative Terminology</a></li>
                           <li><a href="s2173.html#d0e218152">2173.05(c)-Numerical Ranges and Amounts Limitations</a></li>
                           <li><a href="s2173.html#d0e218251">2173.05(d)-Exemplary Claim Language (“for example,” “such as”)</a></li>
                           <li><a href="s2173.html#d0e218320">2173.05(e)-Lack of Antecedent Basis</a></li>
                           <li><a href="s2173.html#d0e218380">2173.05(f)-Reference to Limitations in Another Claim</a></li>
                           <li><a href="s2173.html#d0e218409">2173.05(g)-Functional Limitations</a></li>
                           <li><a href="s2173.html#d0e218467">2173.05(h)-Alternative Limitations</a></li>
                           <li><a href="s2173.html#d0e218588">2173.05(i)-Negative Limitations</a></li>
                           <li><a href="s2173.html#d0e218640">2173.05(j)-Old Combination</a></li>
                           <li><a href="s2173.html#d0e218715">2173.05(k)-Aggregation</a></li>
                           <li><a href="s2173.html#">2173.05(l)-[Reserved]</a></li>
                           <li><a href="s2173.html#d0e218748">2173.05(m)-Prolix</a></li>
                           <li><a href="s2173.html#d0e218755">2173.05(n)-Multiplicity</a></li>
                           <li><a href="s2173.html#d0e218827">2173.05(o)-Double Inclusion</a></li>
                           <li><a href="s2173.html#d0e218855">2173.05(p)-Claim Directed to Product-By- Process or Product and Process</a></li>
                           <li><a href="s2173.html#d0e218952">2173.05(q)-“Use” Claims</a></li>
                           <li><a href="s2173.html#d0e219030">2173.05(r)-Omnibus Claim</a></li>
                           <li><a href="s2173.html#d0e219061">2173.05(s)-Reference to Figures or Tables</a></li>
                           <li><a href="s2173.html#d0e219080">2173.05(t)-Chemical Formula</a></li>
                           <li><a href="s2173.html#d0e219126">2173.05(u)-Trademarks or Trade Names in a Claim</a></li>
                           <li><a href="s2173.html#d0e219164">2173.05(v)-Mere Function of Machine</a></li>
                        </ul>
                     </li>
                     <li><a href="s2173.html#d0e219183">2173.06-Practice Compact Prosecution</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2174.html">2174-Relationship Between the Requirements of 35 U.S.C. 112(a) and (b) or Pre-AIA 35 U.S.C. 112, First and Second Paragraphs</a></li>
               <li xmlns=""><a href="s2175-2180.html">2175-2180-[Reserved]</a></li>
               <li xmlns=""><a href="s2181.html">2181-Identifying and Interpreting a 35 U.S.C. 112(f) or Pre-AIA 35 U.S.C. 112, Sixth Paragraph Limitation</a></li>
               <li xmlns=""><a href="s2182.html">2182-Search and Identification of the Prior Art</a></li>
               <li xmlns=""><a href="s2183.html">2183-Making a Prima Facie Case of Equivalence</a></li>
               <li xmlns=""><a href="s2184.html">2184-Determining Whether an Applicant Has Met the Burden of Proving Nonequivalence After a Prima Facie Case Is Made</a></li>
               <li xmlns=""><a href="s2185.html">2185-Related Issues Under 35 U.S.C. 112(a) or (b) and Pre-AIA 35 U.S.C. 112, First or Second Paragraphs</a></li>
               <li xmlns=""><a href="s2186.html">2186-Relationship to the Doctrine of Equivalents</a></li>
               <li xmlns=""><a href="s2187-2189.html">2187-2189-[Reserved]</a></li>
               <li xmlns=""><a href="s2190.html">2190-Prosecution Laches</a></li>
            </ul>  </div>
         </div>
      </div>  </div>
      <!-- Footer Navigation: /includes/general/footer2.html -->

<!-- Used in: MPEP, CPC -->

<!-- ID = $Id: footer2.html 3354 2013-04-23 18:43:33Z janaki $ -->

<!-- URL = $URL: https://dev-wmb-svn.etc.uspto.gov/repos/live/active_content/trunk/includes/general/footer2.html $ -->





  <div style="text-align:right"> Last Modified: 

     

    03/27/2014 10:10:33 

  </div>

</div>

</div>




<!-- End of footer2.html -->


   </body>
</html>